A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm Adherium, ...

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services. Liz Goldenberg is Bloomberg's Market Specialist for securities finance & liquidity. Before ...